Our Team
Kim brings more than 20 years of experience in investor relations (IR) and corporate communications. Over the past decade, she has held executive leadership roles in the molecular diagnostics industry at both early stage and publicly traded companies. Most recently, Kim led IR and communications for Thrive Earlier Detection during its successful Series B process and acquisition by Exact Sciences. She continued at Exact Sciences as interim head of corporate communications and strategic partner on pipeline products including multi-cancer early detection. Prior to Thrive and Exact, Kim held investor relations and corporate communications roles at Foundation Medicine and Roche. She has a bachelor’s degree from Bucknell University.